Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FIRMUS LABS LTD

NPI: 1235533613 · CLINTON, MD 20735 · Clinical Medical Laboratory · NPI assigned 10/14/2014

$3.30M
Total Medicaid Paid
37,083
Total Claims
25,828
Beneficiaries
55
Codes Billed
2018-01
First Month
2024-10
Last Month

Provider Details

Authorized OfficialWELCH, LEROY (CEO)
NPI Enumeration Date10/14/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 15,111 $1.20M
2019 8,584 $728K
2020 8,440 $930K
2021 1,040 $92K
2022 1,460 $112K
2023 1,703 $173K
2024 745 $73K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 16,160 11,292 $1.91M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 10,280 6,481 $851K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,431 4,509 $308K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 1,640 1,305 $212K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 95 89 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 43 41 $1K
84403 46 45 $1K
82670 42 41 $1K
84443 Thyroid stimulating hormone (TSH) 70 67 $977.32
82627 42 41 $829.60
80061 Lipid panel 69 68 $808.50
84144 42 41 $778.60
84481 47 46 $725.01
82728 90 56 $703.12
83001 42 41 $693.26
83002 42 41 $690.88
83090 44 43 $666.36
82533 42 41 $608.26
84154 37 36 $564.86
83036 Hemoglobin; glycosylated (A1C) 64 63 $554.32
80053 Comprehensive metabolic panel 58 57 $544.73
84466 56 56 $538.66
82607 40 38 $496.20
85025 Blood count; complete (CBC), automated, and automated differential WBC count 72 64 $452.09
84439 47 46 $386.10
82977 57 56 $363.40
83735 57 56 $338.10
84100 57 56 $239.20
84550 57 56 $228.16
80346 39 27 $203.27
83992 336 300 $140.74
80361 22 13 $97.67
80345 39 27 $96.67
80324 39 27 $96.67
80353 39 27 $96.67
80359 39 27 $96.67
80349 39 27 $96.67
80358 39 27 $96.67
80354 39 27 $96.67
80348 39 27 $96.67
80356 39 27 $96.67
86140 43 42 $68.16
80321 22 13 $67.82
80368 22 13 $54.23
80357 22 13 $54.23
80369 22 13 $54.23
80355 22 13 $54.23
80366 22 13 $54.23
82947 57 56 $38.79
80076 49 47 $26.91
80364 22 13 $19.11
80374 39 27 $10.61
85027 38 37 $0.00
80184 39 27 $0.00
84436 47 46 $0.00